The Effectiveness of a Preoperative Use of Misoprostol in Laparoscopically Assisted Vaginal Hysterectomy.
- Author:
Pil Je CHO
1
;
Kyung Jin HWANG
;
Ho Jin CHOI
;
Ho Sun CHANG
;
Yong Buem KIM
;
Mi Ryung KIM
;
Hyuk LEE
;
Hyun Mi KIM
Author Information
1. Department of Obstetrics and Gynecology, Grace Women's Hospital, Koyang, Korea. jpchogd@empal.com
- Publication Type:Original Article
- Keywords:
LAVH;
Misoprostol;
Blood loss
- MeSH:
Female;
Humans;
Hysterectomy, Vaginal*;
Medical Records;
Misoprostol*;
Myoma;
Parity;
Postoperative Complications;
Uterus
- From:Korean Journal of Obstetrics and Gynecology
2005;48(5):1282-1287
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: To investigate the effectiveness of a single preoperative dose of rectal misoprostol in laparoscopically assisted vaginal hysterectomy (LAVH). METHODS: Between October 2003 and July 2004, 63 patients underwent LAVH with a single preoperative dose of rectal misoprostol 400 microgram at Grace women's hospital. To compare efficacy of a single preoperative dose of rectal misoprostol, 63 patients underwent LAVH without misoprostol were sampled during same period at Grace women's hospital. Clinicopathological variables were collected from the review of medical record and compared between two groups. Included variables were age, parity, BMI, uterus weight, largest myoma diameter, operation time, 24 hr Hb change, blood loss during operation, postoperative morbidity and postoperative complication. Associations between variable were studied using paired t-test. RESULTS: There were no significant differences in age, parity, BMI, uterus weight, largest myoma diameter between each groups. Comparing each groups in operative outcomes, estimated blood loss (155.0 +/- 97.8 mL vs 220.1 +/- 82.5 mL) and 24 hr Hb change (1.10 +/- 0.53 g/dL vs 1.57 +/- 0.46 g/dL) were significantly reduced in misoprostol group. CONCLUSION: A single preoperative dose of rectal misoprostol is a simple, reliable method for reducing intraoperative blood loss in LAVH.
